Real life experience with ceftolozane-tazobactam in tertiary hospital

被引：0
|
作者：
Sadyrbaeva-Dolgova, S. [1 ]
Guijarro-Herrera, S. [1 ]
Cancela-Diez, B. [1 ]
Garcia-Fumero, R. [1 ]
Jimenez-Morales, A. [1 ]
机构：
[1] Hosp Univ Virgen Ias Nieves, Granada, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2020年 / 42卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT042
引用
下载
收藏
页码：289 / 290
页数：2
相关论文
共 50 条
  • [41] Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
    Zhanel, George G.
    Dhami, Rita
    Baxter, Melanie
    Kosar, Justin
    Cervera, Carlos
    Irfan, Neal
    Zvonar, Rosemary
    Borgia, Sergio
    Tessier, Jean-Francois
    Dow, Gordon
    Ariano, Robert
    Dube, Maxime
    Savoie, Michel
    Bassetti, Matteo
    Walkty, Andrew
    Karlowsky, James A.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 25 : 346 - 350
  • [42] Ceftolozane-tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study
    Raby, Edward
    Naicker, Saiyuri
    Sime, Fekade Bruck
    Manning, Laurens
    Wallis, Steven C.
    Pandey, Saurabh
    Roberts, Jason A.
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (E1) : E84 - E86
  • [43] Clinical outcomes of ceftolozane-tazobactam dosing in patients with sepsis undergoing renal replacement therapies
    El Nekidy, Wasim S.
    Al Ali, Mooza
    Abidi, Emna
    Ghazi, Islam M.
    Attallah, Nizar
    El Lababidi, Rania
    Hijazi, Fadi
    Mallat, Jihad
    CLINICAL NEPHROLOGY, 2023, 100 (03) : 126 - 131
  • [44] Use of continuous infusion ceftolozane-tazobactam with therapeutic drug monitoring in a patient with cystic fibrosis
    Davis, Sarah Elizabeth
    Ham, Jared
    Hucks, Jennifer
    Gould, Alyssa
    Foster, Rachel
    Justo, Julie Ann
    Nicolau, David P.
    Bookstaver, P. Brandon
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (08) : 501 - 504
  • [45] Finding the Dose for Ceftolozane-Tazobactam in Critically Ill Children with and without Acute Kidney Injury
    Butragueno-Laiseca, Laura
    Troconiz, Inaki F.
    Grau, Santiago
    Campillo, Nuria
    Garcia, Xandra
    Padilla, Belen
    Fernandez, Sarah N.
    Jose Santiago, Maria
    ANTIBIOTICS-BASEL, 2020, 9 (12): : 1 - 14
  • [46] Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model
    Attwood, Marie
    Griffin, Pippa
    Noel, Alan R.
    Albur, Maha
    Macgowan, Alasdair P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (09) : 2254 - 2262
  • [47] Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
    Gerardo Aguilar
    Rafael Ferriols
    Sara Martínez-Castro
    Carlos Ezquer
    Ernesto Pastor
    José A. Carbonell
    Manuel Alós
    David Navarro
    Critical Care, 23
  • [48] Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
    Aguilar, Gerardo
    Ferriols, Rafael
    Martinez-Castro, Sara
    Ezquer, Carlos
    Pastor, Ernesto
    Carbonell, Jose A.
    Alos, Manuel
    Navarro, David
    CRITICAL CARE, 2019, 23 (1):
  • [49] Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infections
    Giancola, Stephanie E.
    Mahoney, Monica V.
    Bias, Tiffany E.
    Hirsch, Elizabeth B.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 787 - 797
  • [50] Continuous infusion of ceftolozane-tazobactam resulted in high cerebrospinal fluid concentrations of ceftolozane in a patient with multidrug-resistantPseudomonas aeruginosameningitis
    Winans, S. Alexander
    Guerrero-Wooley, Richelle L.
    Park, Susie H.
    Hino, Garret, Jr.
    Forland, Steven C.
    INFECTION, 2021, 49 (02) : 355 - 359
12345